title: Effect of IRS4 levels on PI 3-kinase signalling.
abstract: Insulin receptor substrate 1 (IRS1) and IRS2 are well-characterized adapter proteins that relay signals from receptor tyrosine kinases to downstream components of signalling pathways. In contrast, the function of IRS4 is not well understood. IRS4 overexpression has been associated with acute lymphoblastic leukaemia and subungual exostosis, while point mutations of IRS4 have been found in melanomas. Here, we show that while IRS4 expression is low in most cancer cell lines, IRS4 mRNA and protein levels are markedly elevated in certain cells including the NCI-H720, DMS114, HEK293T and HEK293AAV lines. Surprisingly, IRS4 expression was also strongly induced when HEK293 cells were infected with retroviral particles and selected under puromycin, making IRS4 expression a potential off-target effect of retroviral expression vectors. Cells with high expression of IRS4 displayed high phosphatidylinositol (3,4,5)-trisphosphate (PIP3) levels, as well as elevated Akt and p70 S6 kinase activities, even in the absence of growth factors. PI 3-kinase (PI3K) signalling in these cells depends on IRS4, even though these cells also express IRS1/2. Knockdown of IRS4 also inhibited cell proliferation in cells with high levels of IRS4. Together, these findings suggest IRS4 as a potential therapeutic target for cancers with high expression of this protein.
authors.affiliation: Medical Research Council Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
authors.forename: Gerta
authors.initials: G
authors.lastname: Hoxhaj
authors.forename: Kumara
authors.initials: K
authors.lastname: Dissanayake
authors.forename: Carol
authors.initials: C
authors.lastname: MacKintosh
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002466:Cell Nucleolus / Q000378:metabolism; D004789:Enzyme Activation; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D057809:HEK293 Cells; D006801:Humans; D055504:Insulin Receptor Substrate Proteins / Q000032:analysis / Q000235:genetics* / Q000378:metabolism*; D009369:Neoplasms / Q000201:enzymology* / Q000235:genetics* / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D015398:Signal Transduction; D015854:Up-Regulation
chemical_list: C526292:IRS1 protein, human; C107686:IRS4 protein, human; D055504:Insulin Receptor Substrate Proteins; D019869:Phosphatidylinositol 3-Kinases
references.citation: Anal Biochem. 2003 Feb 15;313(2):234-45
references.pmid: 12605860
references.citation: J Clin Invest. 2005 Mar;115(3):718-27
references.pmid: 15711641
references.citation: Neurobiol Aging. 2009 Mar;30(3):474-82
references.pmid: 17720279
references.citation: Am J Physiol Endocrinol Metab. 2000 Jan;278(1):E127-33
references.pmid: 10644546
references.citation: BMC Neurosci. 2011 Sep 28;12:95
references.pmid: 21955513
references.citation: Mol Cell Biol. 1995 Aug;15(8):4232-39
references.pmid: 7542742
references.citation: Biochem Biophys Res Commun. 1999 Jul 14;260(3):718-23
references.pmid: 10403832
references.citation: Oncogene. 2006 Jan 5;25(1):32-42
references.pmid: 16170362
references.citation: J Virol. 2009 Jan;83(1):454-69
references.pmid: 18971280
references.citation: Brain Res Mol Brain Res. 1999 Sep 8;72(1):97-102
references.pmid: 10521603
references.citation: J Biol Chem. 1997 Aug 22;272(34):21403-7
references.pmid: 9261155
references.citation: Int J Cancer. 2011 Jan 15;128(2):487-91
references.pmid: 20340132
references.citation: Oncogene. 2005 Aug 25;24(36):5656-64
references.pmid: 15870689
references.citation: Proc Natl Acad Sci U S A. 2010 May 18;107(20):9270-4
references.pmid: 20439718
references.citation: Mol Cell Biochem. 1998 May;182(1-2):3-11
references.pmid: 9609109
references.citation: J Hepatol. 2007 Jun;46(6):1089-98
references.pmid: 17408801
references.citation: Genes Dev. 2002 Dec 15;16(24):3213-22
references.pmid: 12502742
references.citation: Mol Endocrinol. 2008 Apr;22(4):965-77
references.pmid: 18165436
references.citation: Hepatology. 2003 Jun;37(6):1461-9
references.pmid: 12774026
references.citation: Exp Diabesity Res. 2003 Jul-Sep;4(3):169-82
references.pmid: 15061645
references.citation: Cell Signal. 2009 Sep;21(9):1370-8
references.pmid: 19410646
references.citation: DNA Res. 2012;19(4):305-16
references.pmid: 22490996
references.citation: PLoS One. 2012;7(8):e43369
references.pmid: 22912864
references.citation: Mol Cell Biol. 2004 Mar;24(5):1918-29
references.pmid: 14966273
references.citation: Mol Cell Biol. 2001 Jan;21(1):26-38
references.pmid: 11113178
references.citation: Br J Haematol. 2011 Nov;155(4):516-9
references.pmid: 21517825
references.citation: Mol Cell Biochem. 2006 Dec;293(1-2):35-46
references.pmid: 16933034
references.citation: J Biol Chem. 1998 Apr 24;273(17):10726-32
references.pmid: 9553137
references.citation: Genome Res. 2009 Aug;19(8):1497-505
references.pmid: 19465509
references.citation: Oncogene. 2009 Feb 5;28(5):686-97
references.pmid: 19029952
references.citation: Biochem J. 2011 Jan 15;433(2):357-69
references.pmid: 21087210
references.citation: Diabetes Metab Res Rev. 2000 Nov-Dec;16(6):434-41
references.pmid: 11114102
references.citation: PLoS One. 2011 Feb 25;6(2):e16580
references.pmid: 21364910
references.citation: J Biol Chem. 2004 Nov 5;279(45):46438-47
references.pmid: 15316024
references.citation: Br J Haematol. 2009 Feb;144(4):546-51
references.pmid: 19055661
references.citation: Open Biol. 2012 Jul;2(7):120103
references.pmid: 22870394
references.citation: Neoplasia. 2004 Jan-Feb;6(1):1-6
references.pmid: 15068665
references.citation: J Biol Chem. 2004 Nov 5;279(45):46588-94
references.pmid: 15331607
references.citation: Mol Cell Endocrinol. 2003 Nov 14;209(1-2):17-31
references.pmid: 14604813